Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Acta Oncol. 2019 Nov;58(11):1655-1659. doi: 10.1080/0284186X.2019.1634833. Epub 2019 Aug 13.

Authors

Erik Hellbacher¹, Karin Hjorton¹, Carin Backlin¹, Gunilla Enblad², Christer Sundström², Eva Baecklund¹, Ann Knight¹

Affiliations

¹ Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden.
² Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

PMID: 31407922
DOI: 10.1080/0284186X.2019.1634833

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Cyclophosphamide / therapeutic use
Female
Granulomatosis with Polyangiitis / complications*
Granulomatosis with Polyangiitis / diagnosis
Granulomatosis with Polyangiitis / drug therapy
Granulomatosis with Polyangiitis / mortality
Humans
Immunosuppressive Agents / therapeutic use
Lymphoma / diagnosis
Lymphoma / etiology*
Lymphoma / mortality
Lymphoma / pathology
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
Survival Rate

Substances

Immunosuppressive Agents
Cyclophosphamide